CPT code 87800 denotes a laboratory assay that uses direct nucleic acid probe technology to test a single specimen for multiple infectious organisms. This code is relevant nationally as multiplex molecular diagnostics increasingly inform rapid infectious disease identification, outbreak response, and targeted therapy decisions. The code captures a laboratory method distinct from amplified molecular tests and has implications for coverage policies, billing practices, and lab workflow.

Key payers examined include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the clinical and procedural context for CPT code 87800, an overview of payer coverage patterns where available, benchmarks for typical sites of service such as clinical and hospital laboratories, and policy considerations affecting reimbursement and coding compliance. The publication highlights common billing modifiers and operational considerations pertinent to laboratories that perform multiplex direct probe testing. Data not available in the input will be noted where applicable.